
ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple‐negative breast cancer models
Author(s) -
PolonioAlcalá Emma,
SoléSánchez Sònia,
MuñozGuardiola Pau,
MegíasRoda Elisabet,
PerezMontoyo Héctor,
YesteVelasco Marc,
Alfón Jose,
Lizcano Jose Miguel,
Domènech Carles,
RuizMartínez Santiago,
Puig Teresa
Publication year - 2022
Publication title -
cancer communications
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 53
ISSN - 2523-3548
DOI - 10.1002/cac2.12282
Subject(s) - medicine , carboplatin , triple negative breast cancer , oncology , breast cancer , paclitaxel , chemotherapy , cancer , clinical trial , metastasis , cisplatin